SonoScape Medical Corp
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 19.88 CNY | 37,382 CNY | 17,2 CNY |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - CNY | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 424.837.505 | - | - |
Beschreibung
(automatisch übersetzt)
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery solutions, such as camera systems and flexible endoscopes; veterinary ultrasound and endoscopy solutions; and intravascular intervention products. The company also provides face-to-face and online training for ultrasound and endoscopy systems; technical and spare parts support; preventive maintenance, calibration, breakdown repair, and other field services; and upgrade services. In addition, it is involved in the software industry. SonoScape Medical Corp. was incorporated in 2002 and is headquartered in Shenzhen, China.
| Allgemein | Profitabilität | ||
|---|---|---|---|
| Industriesektor ? | Gesundheitsprodukte | Operative Marge [%] ? | - |
| Marktkapitalisierung ? | - CNY | ROIC [%] ? | - |
| Enterprise Value ? | - CNY | ROIC/WACC ? | - |
| Bewertung | |||
| KGV [TTM] ? | - | EV/FCFF [TTM] ? | - |
| KGV [Forward] ? | - | EV/Sales [TTM] ? | - |
| KUV [TTM] ? | - | EV/EBITDA [TTM] ? | - |
| KBV [TTM] ? | - | ||
| Finanzielle Risiken und Liquidität | |||
| Künstl. Bonität ? | - | Zinsdeckungsgrad ? | - |
| Verschuldungsgrad [Buch] ? | - | Cash Ratio - L1 ? | - |
| Verschuldungsgrad [Markt] ? | - | Quick Ratio - L2 ? | - |
| Current Ratio - L3 ? | - | ||
| Dividenden und Aktienrückkäufe | |||
| Vergangene Jahresdividende ? | - CNY | Ausschüttungsquote ? | - % |
| Erwartete Jahresdividende ? | - CNY | Erwartete Dividendenrendite ? | - % |
| Netto Aktienrückkäufe [TTM] ? | - CNY | Effektive Ausschüttungsquote ? | - % |
| Dividendenauszahlung [TTM] ? | - CNY | Effektive Auszahlungsrendite ? | - % |
| Netto Gesamtauszahlung [TTM] ? | - CNY | ||
Kennzahlen
Gewinn/Verlust
Cash Flow
Dividenden & Aktienrückkäufe
Bilanz
Vergleichbare Unternehmen
| Name | Takani Score ? | Marktkapitalisierung | Industriesektor | Land/Region | KGV TTM | Forward KGV ? | |
|---|---|---|---|---|---|---|---|
![]() | Guangzhou Wondfo Biotech Co Ltd | 22,43 | 1.117.940.761,19 USD | Gesundheitsprodukte | China | - | - |
![]() | Sinocare Inc | 34,6 | 1.287.152.082,227 USD | Gesundheitsprodukte | China | 71.14 | - |
| Edan Instruments Inc | 40,1 | 972.600.860,672 USD | Gesundheitsprodukte | China | 18.93 | 29.07 | |
| MeHow Innovative Ltd. A | 49,91 | 1.996.241.850,266 USD | Gesundheitsprodukte | China | 45.89 | - | |
| Jafron Biomedical Co Ltd | 52,74 | 2.085.426.673,971 USD | Gesundheitsprodukte | China | 23.89 | - | |
| Contec Medical Systems Co Ltd | 12,09 | 609.306.951,987 USD | Gesundheitsprodukte | China | - | - | |
| Shanghai Kinetic Medical Co | 37,69 | 570.142.685,696 USD | Gesundheitsprodukte | China | 21.52 | - | |
![]() | Double Medical Technology Inc | 57,9 | 2.707.752.291,328 USD | Gesundheitsprodukte | China | 28.03 | - |
| Ningbo David Medical Device Co Ltd | 39,55 | 403.681.824 USD | Gesundheitsprodukte | China | 36.5 | - | |
| Lepu Medical Tech Beijing | 31,81 | 3.512.332.278,784 USD | Gesundheitsprodukte | China | 28.67 | 42.74 |


